World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
80
Citations
27882
World Ranking
4025
National Ranking
1988

Kennan C. Marsh publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Kennan C. Marsh sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 262 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Kennan C. Marsh D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kennan C. Marsh sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 80 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Kennan C. Marsh is affiliated with AbbVie in the United States and has contributed extensively to medical research, particularly in the fields of hematology, physiology, public health, environmental and occupational health, parasitology, and genetics.

The scientist's recent publications encompass a range of topics related to parasitic diseases, cancer therapeutics, and pharmacology. Key papers include:

  • Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned, 2020, International Journal for Parasitology
  • Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis, 2021, ACS Infectious Diseases
  • Expanding the Repertoire for "Large Small Molecules": Prodrug ABBV-167 Efficiently Converts to Venetoclax with Reduced Food Effect in Healthy Volunteers, 2021, Molecular Cancer Therapeutics
  • Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates, 2024, Heliyon
  • Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC-HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel, 2024, Pharmacology Research & Perspectives

The scientific output covers a majority focus on medicine, with 26 publications within this primary field. More specifically, research concentration lies in several subfields:

  • Hematology
  • Physiology
  • Public Health, Environmental and Occupational Health
  • Parasitology
  • Genetics

Marsh's work also addresses multiple topics across chronic and acute leukemias as well as parasitic infections and cellular biology, including:

  • Chronic Myeloid Leukemia Treatments
  • Telomeres, Telomerase, and Senescence
  • Parasitic Infections and Diagnostics
  • Chronic Lymphocytic Leukemia Research
  • Retinoids in leukemia and cellular processes
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research

The scientist frequently collaborates with several researchers, as indicated by repeated coauthorships with:

  • Dale J. Kempf
  • Ryan Choi
  • Matthew A. Hulverson
  • Grant R. Whitman
  • Lynn K. Barrett

Marsh has published multiple times in venues notably including:

  • PLoS neglected tropical diseases
  • SSRN Electronic Journal
  • Heliyon
  • International Journal for Parasitology
  • ACS Infectious Diseases

Best Publications

  • ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

    Andrew J Souers;Joel D Leverson;Erwin R Boghaert;Scott L Ackler

  • ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor

    Christin Tse;Alexander R. Shoemaker;Jessica Adickes;Mark G. Anderson

  • Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome.

    Barbara Cool;Bradley Zinker;William Chiou;Lemma Kifle

  • ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

    Cherrie K. Donawho;Yan Luo;Yanping Luo;Thomas D. Penning

  • ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

    D J Kempf;K C Marsh;J F Denissen;E McDonald

  • ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

    Hing L. Sham;Dale J. Kempf;Akhteruzammen Molla;Kennan C. Marsh

  • A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

    Michael F. Jarvis;Prisca Honore;Char Chang Shieh;Mark Chapman

  • Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation

    Le Wang;Keith W. Woods;Qun Li;Kenneth J. Barr

  • Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

    D J Kempf;K C Marsh;G Kumar;A D Rodrigues

  • A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat

    Prisca Honore;Diana Donnelly-Roberts;Marian T. Namovic;Gin Hsieh

  • TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists

    M. Cui;P. Honore;C. Zhong;D. Gauvin

  • Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

    Gerard B. Fox;Timothy A. Esbenshade;Jia Bao Pan;Richard J. Radek

  • A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats

    Prisca Honore;Carol T Wismer;Joseph P Mikusa;Chang Z Zhu

  • A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

    Margaret A. Phillips;Julie Lotharius;Kennan Marsh;John White

  • Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer

    Thomas D Penning;Gui-Dong Zhu;Viraj B Gandhi;Jianchun Gong

  • Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins.

    Cheol-Min Park;Milan Bruncko;Jessica Adickes;Joy Bauch

  • Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.

    T J Opgenorth;A L Adler;S V Calzadilla;W J Chiou

  • Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy.

    Dale J. Kempf;Hing L. Sham;Kennan C. Marsh;Charles A. Flentge

  • Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.

    Clark A Briggs;David J Anderson;Jorge D Brioni;Jerry J Buccafusco;Jerry J Buccafusco

  • A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

    M. A. Phillips;J. Lotharius;K. Marsh;J. White

Frequent Co-Authors

Hing L. Sham
Hing L. Sham Global Blood Therapeutics (United States)
Saul H. Rosenberg
Saul H. Rosenberg AbbVie (United States)
Prisca Honore
Prisca Honore University of Minnesota
Michael W. Decker
Michael W. Decker Abbott (United Kingdom)
Jacob J. Plattner
Jacob J. Plattner Pfizer (United States)
Gerard B. Fox
Gerard B. Fox Georgetown University Medical Center
Sergio Wittlin
Sergio Wittlin Swiss Tropical and Public Health Institute
Eric F. Johnson
Eric F. Johnson AbbVie (United States)
David J. Anderson
David J. Anderson California Institute of Technology
David A. Fidock
David A. Fidock Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry doesn’t just lead to research roles or laboratory work—there are many affordable online pathways in health sciences that broaden your career options. For students seeking a quick entry into healthcare, online associate radiology tech programs provide a way to become radiology technicians with solid job prospects and strong earning potential.

Nutrition and wellness is another fast-growing field. The best dietetics programs can help students advance into roles as registered dietitians or clinical nutrition specialists, which require deep knowledge of biochemistry and human biology.

For those interested in patient care, enrolling in accredited medical assistant programs online offers a pathway into hospitals, clinics, and medical offices. Medical assistants with a biology background may also wish to step up their credentials; medical assistant to lpn programs online are designed for this transition, opening doors to advanced nursing roles.

If you're considering a Biology or Biochemistry degree, these related online opportunities can enhance your expertise and diversify your professional options in healthcare and applied sciences.

Best Scientists Citing Kennan C. Marsh

Trending Scientists

Recently Published Articles